Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-02-26 @ 12:41 AM
Study NCT ID:
NCT00375934
Status:
COMPLETED
Last Update Posted:
2010-09-21
First Post:
2006-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
Sponsor:
Xanodyne Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XP21L-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gary Shangold, M.D. / Chief Medical Officer
Old Organization:
Xanodyne Pharmaceuticals, Inc.